Evodiamine inhibits RANKL‐induced osteoclastogenesis and prevents ovariectomy‐induced bone loss in mice

Postmenopausal osteoporosis (PMO) is a progressive bone disease characterized by the over‐production and activation of osteoclasts in elderly women. In our study, we investigated the anti‐osteoclastogenic effect of evodiamine (EVO) in vivo and in vitro, as well as the underlying mechanism. By using...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cell Mol Med
Päätekijät: Jin, Haiming, Yao, Lingya, Chen, Kai, Liu, Yuhao, Wang, Qingqing, Wang, Ziyi, Liu, Qian, Cao, Zhen, Kenny, Jacob, Tickner, Jennifer, Wang, Xiangyang, Xu, Jiake
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2018
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6307789/
https://ncbi.nlm.nih.gov/pubmed/30451360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13955
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia